ClinicalThought

Share

Program Content

Activities

  • GLP-1 RAs for People Living With HIV
    The Ongoing Weight Debate: Using GLP-1 Receptor Agonists to Address Weight Gain in People Living With HIV
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 08, 2023

  • EACS 2023 Latin America
    Latin America: New HIV Data From EACS 2023
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 08, 2023

  • HBV and Viremia in HIV
    Hepatitis B Reactivation and Low-level Viremia in People Living With HIV
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 09, 2023

  • EACS 2023 PrEP Inequities in Europe
    Addressing PrEP Inequities Across Central and Eastern Europe: EACS 2023
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 09, 2023

  • LA ART IDWeek and EACS 2023
    Real-world Experiences With Long-Acting Injectable ART From IDWeek and EACS 2023
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 09, 2023

  • AntiHBc and HIV Virologic Suppression EACS
    Should We Worry About Hepatitis B Core Antibody Before ART Switch?
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 13, 2023

  • LA PrEP IDWeek EACS
    Adding Long-Acting Injectables to the PrEP Menu
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 14, 2023

  • IDWeek and EACS 2023
    Leveraging Telemedicine for HIV Care: Research From IDWeek and EACS 2023
    Clinical Thought
    Conference Coverage
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 28, 2023

Provided by

ProCE Banner

Supporters

Supported by educational grants from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare